Idogen AB (publ) (OM:IDOGEN) on April 28, 2023, said that it has started talks with a number of stakeholders about a potential reverse takeover of the company. The announcement comes 10 days after the company said that it is considering a reverse takeover of the business as part of its attempts to secure the financing it needs. Earlier in April, the company said that its funds would run out at the end of June.

Idogen has about 4,000 shareholders and about SEK 260 million (USD 25.2 million/EUR 22.8 million) in loss deductions. "If we get a solution to our capital need or an agreement on a reversed merger before the annual general meeting, the board intends to withdraw the proposal for liquidation," acting Chief Executive Officer Christina Herder commented.